K-pop

Baby Monster’s YouTube Channel Surpasses 10 Billion Cumulative Views

K-Pop Girl Group Sets New Record for Fastest Rise to Fame 13 million subscribers

KIM HYUNSIK
2026-09-03 09:37:39
[Edaily Starin KIM HYUNSIK Reporter] YG Entertainment (YG) announced on the 3rd that the cumulative view count on girl group BABYMONSTER’s official YouTube channel has surpassed 10 billion.
(Photo courtesy of YG Entertainment)
BABYMONSTER has been operating its YouTube channel since December 2022. The channel has approximately 13.1 million subscribers. Previously, among K-pop groups, the official YouTube channels of BTS, BLACKPINK, and Stray Kids had already surpassed 10 billion cumulative views.
YG highlighted the significance of this achievement, stating, “Surpassing 10 billion cumulative views was accomplished just 3 years and 8 months after the channel’s launch,” and added, “This sets a new record for the fastest time to reach this milestone by a single K-pop girl group channel.”
A total of 17 videos released by BABYMONSTER have surpassed 100 million views. Among these, the music videos for “SHEESH” and “DRIP” have each garnered over 400 million views.
YG stated, “Not only the music videos but also various behind-the-scenes and original content videos have attracted the attention of global fans, recording view counts as high as tens of millions.”
BABYMONSTER has been on its new world tour, “CHOOM,” since last June. The tour consists of 29 shows across 18 cities worldwide.

Economy

Corporation

IT·Science

Economy

[Reporter's Notebook] Technology Leakage: A Crime That Steals the Nation's Future

Cutting-edge strategic technologies cannot be dismissed as merely the property of a single company. They are core assets that determine the competitiveness of the national economy and shape the future…
2026-09-04 05:00:08

IT·Science

AprilBio Co.,Ltd. Unveils Preclinical Data on Dual-Target RNAi… Accelerating Follow-Up Development

AprilBio Co.,Ltd. CI. (Photo courtesy of AprilBio Co.,Ltd.) AprilBio Co.,Ltd.(397030)has obtained early preclinical data for its dual-target RNA interference (RNAi) candidate. With a single adminis…
2026-09-03 18:15:03